Late evening snack: Exploiting a period of anabolic opportunity in cirrhosis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue 3, 2012, Pages 430-441

  Tsien, Cynthia D ^a   Mccullough, Arthur J ^a   Dasarathy, Srinivasan ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cirrhosis; Late evening snack; Muscle mass; Nutrition; Sarcopenia

Indexed keywords

AMMONIA; NITROGEN; UREA;

AMMONIA BLOOD LEVEL; ARTICLE; DIET THERAPY; HEPATIC ENCEPHALOPATHY; HUMAN; INSULIN RESISTANCE; LATE EVENING SNACK; LIPID OXIDATION; LIVER CIRRHOSIS; MUSCLE ATROPHY; MUSCLE MASS; NITROGEN BALANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; QUALITY OF LIFE; SKELETAL MUSCLE; SURVIVAL; SYSTEMATIC REVIEW;

EID: 84857347318     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06951.x     Document Type: Article

References (72)

1. Nutritional status in cirrhosis. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. J. Hepatol. 1994; 21: 317-25.
2. Campillo B, Richardet JP, Scherman E, Bories PN. Evaluation of nutritional practice in hospitalized cirrhotic patients: results of a prospective study. Nutrition 2003; 19: 515-21.
3. Alberino F, Gatta A, Amodio P etal. Nutrition and survival in patients with liver cirrhosis. Nutrition 2001; 17: 445-50.
4. Selberg O, Bottcher J, Tusch G, Pichlmayr R, Henkel E, Muller MJ. Identification of high- and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997; 25: 652-7.
5. Caregaro L, Alberino F, Amodio P etal. Malnutrition in alcoholic and virus-related cirrhosis. Am. J. Clin. Nutr. 1996; 63: 602-9.
6. Merli M, Riggio O, Dally L. Does malnutrition affect survival in cirrhosis? PINC (Policentrica Italiana Nutrizione Cirrosi). Hepatology 1996; 23: 1041-6.
7. Englesbe MJ, Patel SP, He K etal. Sarcopenia and mortality after liver transplantation. J. Am. Coll. Surg. 2010; 211: 271-8.
8. Figueiredo F, Dickson ER, Pasha T etal. Impact of nutritional status on outcomes after liver transplantation. Transplantation 2000; 70: 1347-52.
9. O'Keefe SJ, Abraham RR, Davis M, Williams R. Protein turnover in acute and chronic liver disease. Acta Chir. Scand. Suppl. 1981; 507: 91-101.
10. Dichi JB, Dichi I, Maio R etal. Whole-body protein turnover in malnourished patients with child class B and C cirrhosis on diets low to high in protein energy. Nutrition 2001; 17: 239-42.
11. Millikan WJ Jr, Henderson JM, Galloway JR etal. In vivo measurement of leucine metabolism with stable isotopes in normal subjects and in those with cirrhosis fed conventional and branched-chain amino acid-enriched diets. Surgery 1985; 98: 405-13.
12. Morrison WL, Bouchier IA, Gibson JN, Rennie MJ. Skeletal muscle and whole-body protein turnover in cirrhosis. Clin. Sci. (Lond.) 1990; 78: 613-19.
13. McCullough AJ, Mullen KD, Kalhan SC. Body cell mass and leucine metabolism in cirrhosis. Gastroenterology 1992; 102: 1325-33.
14. Tessari P, Inchiostro S, Barazzoni R etal. Fasting and postprandial phenylalanine and leucine kinetics in liver cirrhosis. Am. J. Physiol. 1994; 267: E140-9.
15. McCullough AJ, Mullen KD, Kalhan SC. Defective nonoxidative leucine degradation and endogenous leucine flux in cirrhosis during an amino acid infusion. Hepatology 1998; 28: 1357-64.
16. Owen OE, Reichle FA, Mozzoli MA etal. Hepatic, gut, and renal substrate flux rates in patients with hepatic cirrhosis. J. Clin. Invest. 1981; 68: 240-52.
17. Owen OE, Trapp VE, Reichard GA Jr etal. Nature and quantity of fuels consumed in patients with alcoholic cirrhosis. J. Clin. Invest. 1983; 72: 1821-32.
18. Owen OE, Reichard GA Jr. Human forearm metabolism during progressive starvation. J. Clin. Invest. 1971; 50: 1536-45.
19. Brosnan JT. Comments on metabolic needs for glucose and the role of gluconeogenesis. Eur. J. Clin. Nutr. 1999; 53 (Suppl. 1): S107-11.
20. Cordoba J, Cabrera J, Lataif L, Penev P, Zee P, Blei AT. High prevalence of sleep disturbance in cirrhosis. Hepatology 1998; 27: 339-45.
21. Piesman M, Hwang I, Maydonovitch C, Wong RK. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am. J. Gastroenterol. 2007; 102: 2128-34.
22. Kruszynska YT, Home PD, McIntyre N. Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis. Hepatology 1991; 14: 103-11.
23. Sayer AA, Syddall HE, Dennison EM etal. Grip strength and the metabolic syndrome: findings from the Hertfordshire Cohort Study. QJM 2007; 100: 707-13.
24. Dominguez LJ, Barbagallo M. The cardiometabolic syndrome and sarcopenic obesity in older persons. J. Cardiometab. Syndr. 2007; 2: 183-9.
25. Pupim LB, Heimburger O, Qureshi AR, Ikizler TA, Stenvinkel P. Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int. 2005; 68: 2368-74.
26. Miwa Y, Moriwaki H. Nocturnal energy and BCAA supplementation in patients with liver cirrhosis. Hepatol. Res. 2004; 30S: 63-6.
27. Sakaida I, Tsuchiya M, Okamoto M, Okita K. Late evening snack and the change of blood glucose level in patients with liver cirrhosis. Hepatol. Res. 2004; 30S: 67-72.
28. Sako K, Imamura Y, Nishimata H, Tahara K, Kubozono O, Tsubouchi H. Branched-chain amino acids supplements in the late evening decrease the frequency of muscle cramps with advanced hepatic cirrhosis. Hepatol. Res. 2003; 26: 327-9.
29. Plank LD, Gane EJ, Peng S etal. Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: a randomized 12-month trial. Hepatology 2008; 48: 557-66.
30. Chang WK, Chao YC, Tang HS, Lang HF, Hsu CT. Effects of extra-carbohydrate supplementation in the late evening on energy expenditure and substrate oxidation in patients with liver cirrhosis. JPEN J. Parenter. Enteral Nutr. 1997; 21: 96-9.
31. Nakaya Y, Harada N, Kakui S etal. Severe catabolic state after prolonged fasting in cirrhotic patients: effect of oral branched-chain amino-acid-enriched nutrient mixture. J. Gastroenterol. 2002; 37: 531-6.
32. Nakaya Y, Okita K, Suzuki K etal. BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition 2007; 23: 113-20.
33. Yamanaka-Okumura H, Nakamura T, Miyake H etal. Effect of long-term late-evening snack on health-related quality of life in cirrhotic patients. Hepatol. Res. 2010; 40: 470-6.
34. Yamanaka-Okumura H, Nakamura T, Takeuchi H etal. Effect of late evening snack with rice ball on energy metabolism in liver cirrhosis. Eur. J. Clin. Nutr. 2006; 60: 1067-72.
35. Fukushima H, Miwa Y, Ida E etal. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration. JPEN J. Parenter. Enteral Nutr. 2003; 27: 315-22.
36. Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G. Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol. Res. 2001; 21: 199-204.
37. Zillikens MC, van den Berg JW, Wattimena JL, Rietveld T, Swart GR. Nocturnal oral glucose supplementation. The effects on protein metabolism in cirrhotic patients and in healthy controls. J. Hepatol. 1993; 17: 377-83.
38. Swart GR, Zillikens MC, van Vuure JK, van den Berg JW. Effect of a late evening meal on nitrogen balance in patients with cirrhosis of the liver. BMJ 1989; 299: 1202-3.
39. Miwa Y, Shiraki M, Kato M etal. Improvement of fuel metabolism by nocturnal energy supplementation in patients with liver cirrhosis. Hepatol. Res. 2000; 18: 184-9.
40. Gheorghe L, Iacob R, Vadan R, Iacob S, Gheorghe C. Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet. Rom. J. Gastroenterol. 2005; 14: 231-8.
41. Verboeket-van de Venne WP, Westerterp KR, van Hoek B, Swart GR. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver: effects of the pattern of food intake. Gut 1995; 36: 110-16.
42. Marchesini G, Bianchi G, Merli M etal. Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 2003; 124: 1792-801.
43. Alvarez MA, Cabre E, Lorenzo-Zuniga V, Montoliu S, Planas R, Gassull MA. Combining steroids with enteral nutrition: a better therapeutic strategy for severe alcoholic hepatitis? Results of a pilot study. Eur. J. Gastroenterol. Hepatol. 2004; 16: 1375-80.
44. Cabre E, Gonzalez-Huix F, Abad-Lacruz A etal. Effect of total enteral nutrition on the short-term outcome of severely malnourished cirrhotics. A randomized controlled trial. Gastroenterology 1990; 98: 715-20.
45. Lockwood AH, McDonald JM, Reiman RE etal. The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J. Clin. Invest. 1979; 63: 449-60.
46. Olde Damink SW, Jalan R, Dejong CH. Interorgan ammonia trafficking in liver disease. Metab. Brain Dis. 2009; 24: 169-81.
47. Kalaitzakis E, Olsson R, Henfridsson P etal. Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis. Liver Int. 2007; 27: 1194-201.
48. Bonora E, Micciolo R, Ghiatas AA etal. Is it possible to derive a reliable estimate of human visceral and subcutaneous abdominal adipose tissue from simple anthropometric measurements? Metabolism 1995; 44: 1617-25.
49. Mally K, Trentmann J, Heller M, Dittmar M. Reliability and accuracy of segmental bioelectrical impedance analysis for assessing muscle and fat mass in older Europeans: a comparison with dual-energy X-ray absorptiometry. Eur. J. Appl. Physiol. 2011; 111: 1879-87.
50. Bracco D, Thiebaud D, Chiolero RL, Landry M, Burckhardt P, Schutz Y. Segmental body composition assessed by bioelectrical impedance analysis and DEXA in humans. J. Appl. Physiol. 1996; 81: 2580-7.
51. Tagliabue A, Andreoli A, Comelli M etal. Prediction of lean body mass from multifrequency segmental impedance: influence of adiposity. Acta Diabetol. 2001; 38: 93-7.
52. Ellis KJ. Human body composition: in vivo methods. Physiol. Rev. 2000; 80: 649-80.
53. Nair KS, Short KR. Hormonal and signaling role of branched-chain amino acids. J. Nutr. 2005; 135: 1547S-52S.
54. Anthony JC, Anthony TG, Kimball SR, Vary TC, Jefferson LS. Orally administered leucine stimulates protein synthesis in skeletal muscle of postabsorptive rats in association with increased eIF4F formation. J. Nutr. 2000; 130: 139-45.
55. Katsanos CS, Kobayashi H, Sheffield-Moore M, Aarsland A, Wolfe RR. A high proportion of leucine is required for optimal stimulation of the rate of muscle protein synthesis by essential amino acids in the elderly. Am. J. Physiol. Endocrinol. Metab. 2006; 291: E381-7.
56. Marchesini G, Zoli M, Dondi C, Bianchi G, Cirulli M, Pisi E. Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology 1982; 2: 420-5.
57. Gamble JL. The Harvey Lectures, Series XLIII, 1946-1947: physiological information gained from studies on the life raft ration. Nutr. Rev. 1989; 47: 199-201.
58. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br. J. Surg. 1973; 60: 646-9.
59. Arsene D, Bruley des Varranes, Galmiche JP etal. Gastro-oesophageal reflux and alcoholic cirrhosis. A reappraisal. J. Hepatol. 1987; 4: 250-8.
60. Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch. Intern. Med. 2006; 166: 965-71.
61. Orr WC, Harnish MJ. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment. Pharmacol. Ther. 1998; 12: 1033-8.
62. Sherlock S, Summerskill WH, White LP, Phear EA. Portal-systemic encephalopathy: neurological complications of liver disease. Lancet 2011; 2: 453-6.
63. Dasarathy S, McCullough AJ, Muc S etal. Sarcopenia associated with portosystemic shunting is reversed by follistatin. J. Hepatol. 2010; 54: 915-21.
64. Garcia PS, Cabbabe A, Kambadur R, Nicholas G, Csete M. Brief-reports: elevated myostatin levels in patients with liver disease: a potential contributor to skeletal muscle wasting. Anesth. Analg. 2010; 111: 707-9.
65. Jeanplong F, Bass JJ, Smith HK etal. Prolonged underfeeding of sheep increases myostatin and myogenic regulatory factor Myf-5 in skeletal muscle while IGF-I and myogenin are repressed. J. Endocrinol. 2003; 176: 425-37.
66. Larsen AE, Tunstall RJ, Carey KA etal. Actions of short-term fasting on human skeletal muscle myogenic and atrogenic gene expression. Ann. Nutr. Metab. 2006; 50: 476-81.
67. Harber MP, Konopka AR, Jemiolo B, Trappe SW, Trappe TA, Reidy PT. Muscle protein synthesis and gene expression during recovery from aerobic exercise in the fasted and fed states. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010; 299: R1254-62.
68. Chen Y, Ye J, Cao L, Zhang Y, Xia W, Zhu D. Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. Int. J. Biochem. Cell Biol. 2010; 42: 2072-81.
69. de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, Lanni A. Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J. 2007; 21: 3431-41.
70. Salehian B, Mahabadi V, Bilas J, Taylor WE, Ma K. The effect of glutamine on prevention of glucocorticoid-induced skeletal muscle atrophy is associated with myostatin suppression. Metabolism 2006; 55: 1239-47.
71. Bonetto A, Penna F, Minero VG etal. Glutamine prevents myostatin hyperexpression and protein hypercatabolism induced in C2C12 myotubes by tumor necrosis factor-alpha. Amino Acids 2011; 40: 585-94.
72. Murgas TR, Suryawan A, Gazzaneo MC etal. Leucine supplementation of a low-protein meal increases skeletal muscle and visceral tissue protein synthesis in neonatal pigs by stimulating mTOR-dependent translation initiation. J. Nutr. 2010; 140: 2145-52.